Patient Insights

Patients are the center of every treatment decision – and often the least represented in the data brand teams actually use. Spherix reaches patients directly, to capture what claims data and chart audits cannot: lived experience, treatment satisfaction, unmet needs, and what patients tell their providers versus what they hold back.

Where patient and provider perspectives diverge is often the most commercially significant signal available to a brand team – and it's one most market research misses entirely.

Download the Publication Plan

Your guide to every Spherix publication scheduled for 2026, organized by therapeutic area, indication, and deliverable, spanning all eight therapeutic franchises and the Market Access practice across US, EU5, and select global markets.

DOWNLOAD PLAN →

Patient Solutions

Understanding the patient experience requires more than survey data – it requires access to patients who reflect the real-world complexity of living with a specialty condition, and the therapeutic expertise to know what questions actually matter.

What Spherix delivers goes beyond the research itself. Every engagement includes access to our therapeutic area experts who can contextualize findings, pressure-test assumptions, and translate data into commercial implications. Custom data cuts, targeted analyses, and strategic working sessions are available across all patient research products – so the output is calibrated to the decisions your team is actually facing, not a standard report handed over at delivery.

AI speeds the path from data collection to synthesis; the interpretation still comes from a specialist who knows the therapeutic area.

Independent primary research, and AI-enhanced analysis to deliver timely, actionable insights across organizations shaping today's access landscape. Every insight is reviewed and validated by a Spherix Market Access specialist before it reaches your team. AI helps synthesize findings across studies, accounts, and stakeholder groups, while experienced analysts provide the context, interpretation and quality control needed to transform primary research into meaningful intelligence.

Anonymized patient-level data gathered through collaboration with specialty providers, who provide details on clinical and non-clinical patient demographics along with rationale for treatment choices. Annual reports with global insights from US, EU5, China, Japan and other select regions. Samples scale with disease prevalence at 100+ patients in extremely rare conditions, and up to 1,250+ patient charts in others.

Multi-stakeholder structured intelligence on patient services programs – competitive benchmarking, strategic assessments, and best-practice learnings. Twice-yearly cadence with quant n=100-175 providers, n=100-175 office staff, n=100-175 patients per study, plus n=6-8 provider interviews. Available across Autoimmune, Oncology, Rare Diseases, and Women's Health, with additional indications on request.

The Spherix Difference

Patient research depends on more than sample size. Its value is shaped by access to the right patients, the quality of the methodology, and the expertise applied to interpreting what patients share.

Spherix combines established advocacy relationships, direct patient engagement, and deep therapeutic-area knowledge to reach individuals who may be difficult to identify through traditional research panels. This includes recently diagnosed patients, those with treatment-resistant disease, and populations whose experiences are often underrepresented in conventional research.

What distinguishes the Spherix approach:

Access beyond standard research panels. Partnerships with patient advocacy organizations and a dedicated Community team help identify and engage patients whose experiences may otherwise be missed.

The right patients for each research question. Targeted recruitment and AI-enhanced qualification help ensure respondents reflect the clinical, treatment, and demographic characteristics most relevant to the study rather than simply increasing sample volume.

Quantitative scale combined with qualitative depth. Research can integrate structured surveys with in-depth interviews to reveal both what patients report and the experiences, expectations, and tradeoffs behind their responses.

More than a decade of longitudinal patient insight. Continuously refreshed research provides context for understanding how patient experiences, treatment expectations, and unmet needs are changing over time.

Specialist-led interpretation. AI-assisted synthesis supports the organization and analysis of complex findings, but every conclusion is reviewed and validated by a Spherix patient-research specialist before delivery.

Direct access to research expertise. Clients can engage with Spherix specialists through working sessions designed to interpret findings, explore implications, and connect patient insight to broader clinical and commercial questions.